Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 15 studies | 28% ± 12% | |
macrophage | 10 studies | 20% ± 6% | |
conventional dendritic cell | 8 studies | 29% ± 19% | |
dendritic cell | 7 studies | 29% ± 15% | |
endothelial cell of artery | 5 studies | 20% ± 6% | |
plasmacytoid dendritic cell | 5 studies | 20% ± 5% | |
endothelial cell | 4 studies | 21% ± 3% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 2% | |
non-classical monocyte | 3 studies | 21% ± 2% | |
common myeloid progenitor | 3 studies | 25% ± 5% | |
myeloid cell | 3 studies | 25% ± 3% | |
monocyte | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2548.21 | 652 / 653 | 100% | 20.54 | 605 / 605 |
ovary | 100% | 1855.88 | 180 / 180 | 99% | 16.64 | 426 / 430 |
lung | 100% | 4580.06 | 578 / 578 | 97% | 15.90 | 1121 / 1155 |
prostate | 100% | 2828.55 | 245 / 245 | 97% | 13.00 | 485 / 502 |
breast | 100% | 3072.39 | 459 / 459 | 96% | 11.68 | 1072 / 1118 |
uterus | 99% | 2860.30 | 169 / 170 | 95% | 16.15 | 436 / 459 |
bladder | 100% | 2227.62 | 21 / 21 | 94% | 15.09 | 474 / 504 |
kidney | 98% | 1531.84 | 87 / 89 | 93% | 13.39 | 836 / 901 |
skin | 92% | 980.59 | 1672 / 1809 | 97% | 27.89 | 458 / 472 |
liver | 100% | 1878.82 | 225 / 226 | 90% | 18.48 | 364 / 406 |
intestine | 100% | 1742.22 | 964 / 966 | 85% | 8.23 | 448 / 527 |
adrenal gland | 98% | 1127.13 | 253 / 258 | 79% | 6.60 | 181 / 230 |
stomach | 87% | 1098.04 | 314 / 359 | 89% | 8.67 | 254 / 286 |
esophagus | 90% | 1385.39 | 1298 / 1445 | 83% | 7.21 | 152 / 183 |
pancreas | 66% | 556.36 | 216 / 328 | 98% | 20.46 | 175 / 178 |
brain | 60% | 488.46 | 1581 / 2642 | 95% | 10.27 | 670 / 705 |
adipose | 100% | 3931.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 22.30 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.99 | 29 / 29 |
spleen | 100% | 16059.39 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.03 | 1 / 1 |
heart | 99% | 1473.89 | 856 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1729.47 | 1326 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 9906.05 | 879 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 9.83 | 42 / 45 |
muscle | 48% | 346.58 | 382 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0071305 | Biological process | cellular response to vitamin D |
GO_0043304 | Biological process | regulation of mast cell degranulation |
GO_0060627 | Biological process | regulation of vesicle-mediated transport |
GO_0006935 | Biological process | chemotaxis |
GO_0007155 | Biological process | cell adhesion |
GO_0045657 | Biological process | positive regulation of monocyte differentiation |
GO_0031116 | Biological process | positive regulation of microtubule polymerization |
GO_0007098 | Biological process | centrosome cycle |
GO_0060038 | Biological process | cardiac muscle cell proliferation |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0051450 | Biological process | myoblast proliferation |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_2000145 | Biological process | regulation of cell motility |
GO_0008360 | Biological process | regulation of cell shape |
GO_0045639 | Biological process | positive regulation of myeloid cell differentiation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0001578 | Biological process | microtubule bundle formation |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0034987 | Molecular function | immunoglobulin receptor binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0008017 | Molecular function | microtubule binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FES |
Protein name | Fes/fps proto-oncogene FES proto-oncogene, tyrosine kinase C-fes/fps protein Tyrosine-protein kinase (EC 2.7.10.2) Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) |
Synonyms | FPS |
Description | FUNCTION: Tyrosine-protein kinase that acts downstream of cell surface receptors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, cell attachment and cell spreading. Plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Acts down-stream of the activated FCER1 receptor and the mast/stem cell growth factor receptor KIT. Plays a role in the regulation of mast cell degranulation. Plays a role in the regulation of cell differentiation and promotes neurite outgrowth in response to NGF signaling. Plays a role in cell scattering and cell migration in response to HGF-induced activation of EZR. Phosphorylates BCR and down-regulates BCR kinase activity. Phosphorylates HCLS1/HS1, PECAM1, STAT3 and TRIM28. . |
Accessions | ENST00000559355.5 E7EMJ7 ENST00000394300.7 [P07332-3] Q4JFK7 ENST00000443697.1 Q4JFK8 ENST00000414248.6 [P07332-2] H0YNT6 H0YNN8 ENST00000394302.5 C9J3W6 ENST00000444422.2 [P07332-4] ENST00000464684.5 E9PIJ7 ENST00000470152.6 P07332 ENST00000328850.8 [P07332-1] E7ENM8 ENST00000452243.5 ENST00000416779.1 E9PGC7 |